Jazz Pharmaceuticals plc Cash
Jazz Pharmaceuticals plc (JAZZ) had Cash of $703.00 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-03
- 2026-06-30: Cash $703.00M.
- 2026-03-31: Cash $667.50M.
- 2025-12-31: Cash $682.70M.
- 2012-03-31: Cash $104.64M.
| Period end | Cash |
|---|---|
| 2026-06-30 | $703.00M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $667.50M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $682.70M 10-Q · filed 2026-08-03 |
| 2012-03-31 | $104.64M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $33.31M 10-Q · filed 2012-05-08 |
| 2010-12-31 | $19.75M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |